Page 37 - Read Online
P. 37

Padilla et al. Rare Dis Orphan Drugs J 2023;2:27                    Rare Disease and
               DOI: 10.20517/rdodj.2023.38
                                                                            Orphan Drugs Journal




               Perspective                                                                   Open Access



               Overcoming challenges in sustaining newborn
               screening in low-middle-income countries: the

               Philippine newborn screening system


                                                                           2
                                                        2
               Carmencita D. Padilla 1,2  , Michelle E. Abadingo , Katherine V. Munda , Bradford L. Therrell 3,4
               1
                Department of Pediatrics, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.
               2
                Newborn Screening Reference Center, National Institutes of Health, University of the Philippines Manila, Manila 1000,
               Philippines.
               3
                Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, TX 78249, USA.
               4
                National Newborn Screening and Global Resource Center, Austin, TX 78759, USA.
               Correspondence to: Prof. Carmencita D. Padilla, Department of Pediatrics, College of Medicine, University of the Philippines
               Manila, Taft Avenue, Manila 1000, Philippines. E-mail: cdpadilla@up.edu.ph
               How to cite this article: Padilla CD, Abadingo ME, Munda KV, Therrell BL. Overcoming challenges in sustaining newborn
               screening in low-middle-income countries: the Philippine newborn screening system. Rare Dis Orphan Drugs J 2023;2:27.
               https:/ /dx.doi.org/10.20517/rdodj.2023.38
               Received: 1 Oct 2023  First Decision: 1 Nov 2023  Revised: 13 Nov 2023  Accepted: 29 Nov 2023  Published: 11 Dec 2023

               Academic Editor: Daniel Scherman  Copy Editor: Dan Zhang  Production Editor: Dan Zhang

               Abstract
               Newborn screening (NBS) was introduced in the Philippines in 1996, and the Newborn Screening Act of 2004
               mandated its provision to all Filipino newborns. The program initially covered five conditions and has expanded to
               the current panel of 29 conditions. This report focuses on the steps taken for successful NBS implementation and
               the challenges that must be overcome to make NBS sustainable. While often considered a public health program,
               NBS is really a system of interacting parts that must be carefully considered and planned prior to embarking on
               their implementation. The basic challenges are the same in both high-income and low-middle-income countries
               (LMICs), but they are more difficult to overcome in LMICs. In addition to the technical aspects of screening,
               including supplies and maintenance, considerations must include human resources, professional and public
               education, and government support. Challenges may occur at any point in implementation and continuation, and it
               is important to learn from the experiences of others in order to make the process more efficient. Here, we report on
               the experiences in one LMIC, the Philippines, in creating and sustaining a NBS system so that others may gain from
               these experiences.

               Keywords: Newborn screening, Philippines, public health, bloodspot screening, screening system





                           © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                       www.oaepublish.com/rdodj
   32   33   34   35   36   37   38   39   40   41   42